{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:21:59Z","timestamp":1782296519060,"version":"3.54.5"},"reference-count":36,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005933","name":"Camurus Lipid Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005933","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Delivery"],"published-print":{"date-parts":[[2024,5,3]]},"DOI":"10.1080\/17425247.2024.2369756","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T06:05:15Z","timestamp":1718863515000},"page":"809-815","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["Compared implementation of the long-acting buprenorphine treatment buvidal in four European countries"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8666-3635","authenticated-orcid":false,"given":"Benjamin","family":"Rolland","sequence":"first","affiliation":[{"name":"Service Universitaire d\u2019Addictologie de Lyon (SUAL), Hospices Civils de Lyon, CH Le Vinatier, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7568-1125","authenticated-orcid":false,"given":"Catriona","family":"Matheson","sequence":"additional","affiliation":[{"name":"Faculty of Social Sciences, Colin Bell Building, University of Stirling, Stirling, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Kaski","sequence":"additional","affiliation":[{"name":"Kuopio Addiction Medicine Center, P\u00e4ihdepalvelus\u00e4\u00e4ti\u00f6, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9874-8978","authenticated-orcid":false,"given":"Margaux","family":"Kosim","sequence":"additional","affiliation":[{"name":"Camurus SAS, Paris, France"},{"name":"Assistance Publique- H\u00f4pitaux de Paris, GHU Sorbonne Universit\u00e9, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Consultations de m\u00e9decine-Alcoologie PASS, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1829-1456","authenticated-orcid":false,"given":"Carlos","family":"Roncero","sequence":"additional","affiliation":[{"name":"Unidad de Psiquiatr\u00eda, Facultad de Medicinia, Universidad de Salamanca &amp; Instituto de Biomedicina (IBSAL), Spain; Universidad de Salamanca, C, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5168-3727","authenticated-orcid":false,"given":"Florence","family":"Vorspan","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, UFR de M\u00e9decine et INSERM UMRS 1144, Paris, France; D\u00e9partement de Psychiatrie et de M\u00e9decine Addictologique, H\u00f4pital Fernand Widal, GHU NORD, Assistance Publique - H\u00f4pitaux de, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,6,19]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0137-5"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2019.06.020"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2020.05.007"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108492"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14941"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1159\/000520091"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2019.1649252"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1298-4508"},{"key":"#cr-split#-e_1_3_5_10_1.1","unstructured":"European Medicines Agency (EMA). Sixmo\u00ae: overview. [Updated 2023 Feb 20"},{"key":"#cr-split#-e_1_3_5_10_1.2","unstructured":"cited 2023 Feb 20]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/sixmo"},{"key":"e_1_3_5_11_1","unstructured":"National Health Service (NHS). Prescription data. [cited 2024 Jan 2]. Available from: https:\/\/www.nhsbsa.nhs.uk\/prescription-data"},{"key":"e_1_3_5_12_1","unstructured":"Health and Social Care Northern Ireland. General Pharmaceutical Services and Prescribing Statistics. [cited 2024 Jan 2]. Available from: https:\/\/bso.hscni.net\/directorates\/operations\/family-practitioner-services\/directorates-operations-family-practitioner-services-information-unit\/general-pharmaceutical-services-and-prescribing-statistics\/"},{"key":"e_1_3_5_13_1","unstructured":"National Health Service Wales. Prescription data extracts. [cited 2024 Jan 2]. Available from: https:\/\/nwssp.nhs.wales\/ourservices\/primary-care-services\/general-information\/data-and-publications\/"},{"key":"e_1_3_5_14_1","unstructured":"Scottish Public Health Observatory (ScotPHO). Opioid Substitution Therapy (OST) Drug Prescribing. [cited 2024 Jan 2]. Available from: https:\/\/www.scotpho.org.uk\/risk-factors\/drugs\/data\/prescribing-for-drug-use\/"},{"key":"e_1_3_5_15_1","unstructured":"Drug Research Network Scotland (DRNS). Long acting injectable buprenorphine: knowledge exchange event. [cited 2024 Jan 2]. Available from: https:\/\/drns.ac.uk\/long-acting-injectable-buprenorphine-knowledge-exchange-event\/"},{"key":"e_1_3_5_16_1","unstructured":"Community Pharmacy News. Pharmacy pilots \u2018game changing\u2019 buprenorphine injection. [Updated 2021 Jul 8 cited 2021 Jul 8]. Available from: https:\/\/www.chemistanddruggist.co.uk\/CD005980\/Pharmacy-pilots-game-changing-buprenorphine-injection;"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108781"},{"key":"e_1_3_5_19_1","first-page":"e32696","article-title":"Opioidikorvaushoidossa olevien m\u00e4\u00e4r\u00e4 on jatkanut kasvuaan [The number of people on opioid substitution treatment has continued to rise in 2019]","volume":"77","author":"Partanen A","year":"2022","unstructured":"Partanen A, Alho H, Kuussaari K, et al. Opioidikorvaushoidossa olevien m\u00e4\u00e4r\u00e4 on jatkanut kasvuaan [The number of people on opioid substitution treatment has continued to rise in 2019]. Suom L\u00e4\u00e4k\u00e4ril. 2022 [cited 2024 Jan 2];77:e32696. Available from: www.laakarilehti.fi\/e32696","journal-title":"Suom L\u00e4\u00e4k\u00e4ril"},{"key":"e_1_3_5_20_1","unstructured":"Finlex. Sosiaali- ja terveysministeri\u00f6n asetus opioidiriippuvaisten vieroitus- ja korvaushoidosta opioidil\u00e4\u00e4kkeill\u00e4 [Decree of the Ministry of Social Affairs and Health on withdrawal and substitution treatment of opioid addiction with opioid medicine]. [Updated 2023 Mar 29; cited 2023 Mar 29]."},{"key":"#cr-split#-e_1_3_5_21_1.1","unstructured":"Council of Europe. Council for penological co-operation (pc-cp). Replies to the questionnaire on mental disorders and disabilities of persons in penal detention). [Updated 2021 May 10"},{"key":"#cr-split#-e_1_3_5_21_1.2","unstructured":"cited 2021 May 10]. Available from: https:\/\/rm.coe.int\/pc-cp-2021-4-e-replies-to-questionnaire-on-mental-health-in-prisons\/1680a25a8c"},{"key":"e_1_3_5_22_1","unstructured":"EMCDDA. Finland Country Report; 06\/06\/2019. [cited 2024 Jan 2]. Available from: https:\/\/www.emcdda.europa.eu\/publications\/country-drug-reports\/2019\/finland_en"},{"key":"e_1_3_5_23_1","unstructured":"Ministerio de Sanidad. BIFIMED: Buscador de la Informaci\u00f3n sobre la situaci\u00f3n de financiaci\u00f3n de los medicamentos - Nomencl\u00e1tor de DICIEMBRE \u2013 2023\/Buprenorfina. [BIFIMED: Search engine for information on the financing situation of medicines - Nomenclature of DECEMBER \u2013 2023\/Buprenorphine]. [cited 2024 Jan 2]. Available from: https:\/\/www.sanidad.gob.es\/profesionales\/medicamentos.do?metodo=verDetalle&cn=725941"},{"key":"e_1_3_5_24_1","unstructured":"Ministerio de Sanidad y Seguridad Social. \u00abBOE\u00bb n\u00fam. 274 de 16 de noviembre de 1977 Referencia: BOE-A-1977-27160. [cited 2024 Jan 2]. Available from: https:\/\/www.boe.es\/buscar\/pdf\/1977\/BOE-A-1977-27160-consolidado.pdf"},{"key":"e_1_3_5_25_1","unstructured":"Observatoire Fran\u00e7ais des Drogues et Tendances addictives (OFDT). Tableau de bord \u00ab Traitements de substitution aux opio\u00efdes \u00bb 2020 [\u201dOpioid Substitution Treatments\u201d 2020 scoreboard]. [Updated 2020 Jan 9; cited 2020 Jan 9]. Available from: https:\/\/www.ofdt.fr\/publications\/collections\/bilans\/tableau-de-bord-traitements-de-substitution-aux-opioides-2020\/"},{"key":"#cr-split#-e_1_3_5_26_1.1","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (HAS). Buvidal. [Updated 2021 Mar 22"},{"key":"#cr-split#-e_1_3_5_26_1.2","unstructured":"cited 2021 Mar 22]. Available from: https:\/\/www.has-sante.fr\/jcms\/p_3244165\/fr\/buvidal-buprenorphine;"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108959"},{"key":"#cr-split#-e_1_3_5_28_1.1","unstructured":"Minist\u00e8re de la Sant\u00e9 et de la Pr\u00e9vention. Bulletin officiel \u00ab Sant\u00e9 Protection sociale Solidarit\u00e9 \u00bb N\u00b0 24. [Updated 2022 Nov 30"},{"key":"#cr-split#-e_1_3_5_28_1.2","unstructured":"cited 2022 Nov 30]. Available from: https:\/\/sante.gouv.fr\/fichiers\/bo\/2022\/2022.24.sante.pdf;"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2013.08.007"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1159\/000516165"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000647"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2013.02.001"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-4-5"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.16420"}],"container-title":["Expert Opinion on Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2024.2369756","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T21:25:45Z","timestamp":1727213145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425247.2024.2369756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,3]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5,3]]}},"alternative-id":["10.1080\/17425247.2024.2369756"],"URL":"https:\/\/doi.org\/10.1080\/17425247.2024.2369756","relation":{},"ISSN":["1742-5247","1744-7593"],"issn-type":[{"value":"1742-5247","type":"print"},{"value":"1744-7593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-01-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}